neurocognitive evaluations

BEHAVIORAL2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, IRCCS Eugenio Medea

Conditions

Lymphoma Receiving CAR-T TherapyMyotonic Dystrophy 1

Unknown Phase

Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy

RecruitingNCT04107285

Memorial Sloan Kettering Cancer CenterLymphoma Receiving CAR-T Therapy

Start: 2019-09-25End: 2026-09-30Target: 120Updated: 2025-10-24

Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]

RecruitingNCT06378216

IRCCS Eugenio MedeaMyotonic Dystrophy 1

Start: 2022-09-15End: 2024-12-30Target: 30Updated: 2024-04-22